Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
102 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report focuses on the global Urological Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urological Cancer Drugs development in United States, Europe and China. In 2017, the global Urological Cancer Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study Novartis Pfizer Johnson & Johnson AstraZeneca Astellas Bristol-Myers Squibb Abbott Laboratories Celgene Corporation Dendreon Corporation Ferring Pharmaceuticals GlaxoSmithKline Indevus Pharmaceuticals Inc Ipsen Roche Healthcare Sanofi S.A Tolmar Inc Market segment by Type, the product can be split into Tablets Injection Market segment by Application, split into Prostate Cancer Bladder Cancer Kidney Cancer Testicular Cancer Other Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Urological Cancer Drugs status, future forecast, growth opportunity, key market and key players. To present the Urological Cancer Drugs development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Urological Cancer Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Urological Cancer Drugs Market Size Growth Rate by Type (2013-2025) 1.4.2 Tablets 1.4.3 Injection 1.5 Market by Application 1.5.1 Global Urological Cancer Drugs Market Share by Application (2013-2025) 1.5.2 Prostate Cancer 1.5.3 Bladder Cancer 1.5.4 Kidney Cancer 1.5.5 Testicular Cancer 1.5.6 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Urological Cancer Drugs Market Size 2.2 Urological Cancer Drugs Growth Trends by Regions 2.2.1 Urological Cancer Drugs Market Size by Regions (2013-2025) 2.2.2 Urological Cancer Drugs Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Urological Cancer Drugs Market Size by Manufacturers 3.1.1 Global Urological Cancer Drugs Revenue by Manufacturers (2013-2018) 3.1.2 Global Urological Cancer Drugs Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Urological Cancer Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Urological Cancer Drugs Key Players Head office and Area Served 3.3 Key Players Urological Cancer Drugs Product/Solution/Service 3.4 Date of Enter into Urological Cancer Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Urological Cancer Drugs Market Size by Type (2013-2018) 4.2 Global Urological Cancer Drugs Market Size by Application (2013-2018) 5 United States 5.1 United States Urological Cancer Drugs Market Size (2013-2018) 5.2 Urological Cancer Drugs Key Players in United States 5.3 United States Urological Cancer Drugs Market Size by Type 5.4 United States Urological Cancer Drugs Market Size by Application 6 Europe 6.1 Europe Urological Cancer Drugs Market Size (2013-2018) 6.2 Urological Cancer Drugs Key Players in Europe 6.3 Europe Urological Cancer Drugs Market Size by Type 6.4 Europe Urological Cancer Drugs Market Size by Application 7 China 7.1 China Urological Cancer Drugs Market Size (2013-2018) 7.2 Urological Cancer Drugs Key Players in China 7.3 China Urological Cancer Drugs Market Size by Type 7.4 China Urological Cancer Drugs Market Size by Application 8 Japan 8.1 Japan Urological Cancer Drugs Market Size (2013-2018) 8.2 Urological Cancer Drugs Key Players in Japan 8.3 Japan Urological Cancer Drugs Market Size by Type 8.4 Japan Urological Cancer Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Urological Cancer Drugs Market Size (2013-2018) 9.2 Urological Cancer Drugs Key Players in Southeast Asia 9.3 Southeast Asia Urological Cancer Drugs Market Size by Type 9.4 Southeast Asia Urological Cancer Drugs Market Size by Application 10 India 10.1 India Urological Cancer Drugs Market Size (2013-2018) 10.2 Urological Cancer Drugs Key Players in India 10.3 India Urological Cancer Drugs Market Size by Type 10.4 India Urological Cancer Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Urological Cancer Drugs Market Size (2013-2018) 11.2 Urological Cancer Drugs Key Players in Central & South America 11.3 Central & South America Urological Cancer Drugs Market Size by Type 11.4 Central & South America Urological Cancer Drugs Market Size by Application 12 International Players Profiles 12.1 Novartis 12.1.1 Novartis Company Details 12.1.2 Company Description and Business Overview 12.1.3 Urological Cancer Drugs Introduction 12.1.4 Novartis Revenue in Urological Cancer Drugs Business (2013-2018) 12.1.5 Novartis Recent Development 12.2 Pfizer 12.2.1 Pfizer Company Details 12.2.2 Company Description and Business Overview 12.2.3 Urological Cancer Drugs Introduction 12.2.4 Pfizer Revenue in Urological Cancer Drugs Business (2013-2018) 12.2.5 Pfizer Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Details 12.3.2 Company Description and Business Overview 12.3.3 Urological Cancer Drugs Introduction 12.3.4 Johnson & Johnson Revenue in Urological Cancer Drugs Business (2013-2018) 12.3.5 Johnson & Johnson Recent Development 12.4 AstraZeneca 12.4.1 AstraZeneca Company Details 12.4.2 Company Description and Business Overview 12.4.3 Urological Cancer Drugs Introduction 12.4.4 AstraZeneca Revenue in Urological Cancer Drugs Business (2013-2018) 12.4.5 AstraZeneca Recent Development 12.5 Astellas 12.5.1 Astellas Company Details 12.5.2 Company Description and Business Overview 12.5.3 Urological Cancer Drugs Introduction 12.5.4 Astellas Revenue in Urological Cancer Drugs Business (2013-2018) 12.5.5 Astellas Recent Development 12.6 Bristol-Myers Squibb 12.6.1 Bristol-Myers Squibb Company Details 12.6.2 Company Description and Business Overview 12.6.3 Urological Cancer Drugs Introduction 12.6.4 Bristol-Myers Squibb Revenue in Urological Cancer Drugs Business (2013-2018) 12.6.5 Bristol-Myers Squibb Recent Development 12.7 Abbott Laboratories 12.7.1 Abbott Laboratories Company Details 12.7.2 Company Description and Business Overview 12.7.3 Urological Cancer Drugs Introduction 12.7.4 Abbott Laboratories Revenue in Urological Cancer Drugs Business (2013-2018) 12.7.5 Abbott Laboratories Recent Development 12.8 Celgene Corporation 12.8.1 Celgene Corporation Company Details 12.8.2 Company Description and Business Overview 12.8.3 Urological Cancer Drugs Introduction 12.8.4 Celgene Corporation Revenue in Urological Cancer Drugs Business (2013-2018) 12.8.5 Celgene Corporation Recent Development 12.9 Dendreon Corporation 12.9.1 Dendreon Corporation Company Details 12.9.2 Company Description and Business Overview 12.9.3 Urological Cancer Drugs Introduction 12.9.4 Dendreon Corporation Revenue in Urological Cancer Drugs Business (2013-2018) 12.9.5 Dendreon Corporation Recent Development 12.10 Ferring Pharmaceuticals 12.10.1 Ferring Pharmaceuticals Company Details 12.10.2 Company Description and Business Overview 12.10.3 Urological Cancer Drugs Introduction 12.10.4 Ferring Pharmaceuticals Revenue in Urological Cancer Drugs Business (2013-2018) 12.10.5 Ferring Pharmaceuticals Recent Development 12.11 GlaxoSmithKline 12.12 Indevus Pharmaceuticals Inc 12.13 Ipsen 12.14 Roche Healthcare 12.15 Sanofi S.A 12.16 Tolmar Inc 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Urological Cancer Drugs Key Market Segments Table Key Players Urological Cancer Drugs Covered Table Global Urological Cancer Drugs Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global Urological Cancer Drugs Market Size Market Share by Type 2013-2025 Figure Tablets Figures Table Key Players of Tablets Figure Injection Figures Table Key Players of Injection Table Global Urological Cancer Drugs Market Size Growth by Application 2013-2025 (Million US$) Figure Prostate Cancer Case Studies Figure Bladder Cancer Case Studies Figure Kidney Cancer Case Studies Figure Testicular Cancer Case Studies Figure Other Case Studies Figure Urological Cancer Drugs Report Years Considered Table Global Urological Cancer Drugs Market Size 2013-2025 (Million US$) Figure Global Urological Cancer Drugs Market Size and Growth Rate 2013-2025 (Million US$) Table Global Urological Cancer Drugs Market Size by Regions 2013-2025 (Million US$) Table Global Urological Cancer Drugs Market Size by Regions 2013-2018 (Million US$) Table Global Urological Cancer Drugs Market Share by Regions 2013-2018 Figure Global Urological Cancer Drugs Market Share by Regions 2013-2018 Figure Global Urological Cancer Drugs Market Share by Regions 2018 Table Market Top Trends Table Global Urological Cancer Drugs Revenue by Manufacturers (2013-2018) (Million US$) Table Global Urological Cancer Drugs Market Share by Manufacturers (2013-2018) Figure Global Urological Cancer Drugs Market Share by Manufacturers in 2018 Table Global Urological Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Urological Cancer Drugs Product/Solution/Service Table Date of Enter into Urological Cancer Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table Global Urological Cancer Drugs Market Size Share by Type (2013-2018) Figure Global Urological Cancer Drugs Market Size Market Share by Type (2013-2018) Table Global Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table Global Urological Cancer Drugs Market Size Share by Application (2013-2018) Figure Global Urological Cancer Drugs Market Size Market Share by Application (2013-2018) Figure Global Urological Cancer Drugs Revenue Market Share by Application in 2017 Figure United States Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table United States Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table United States Key Players Urological Cancer Drugs Market Share (2017-2018) Table United States Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table United States Urological Cancer Drugs Market Share by Type (2013-2018) Table United States Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table United States Urological Cancer Drugs Market Share by Application (2013-2018) Figure Europe Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table Europe Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table Europe Key Players Urological Cancer Drugs Market Share (2017-2018) Table Europe Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table Europe Urological Cancer Drugs Market Share by Type (2013-2018) Table Europe Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table Europe Urological Cancer Drugs Market Share by Application (2013-2018) Figure China Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table China Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table China Key Players Urological Cancer Drugs Market Share (2017-2018) Table China Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table China Urological Cancer Drugs Market Share by Type (2013-2018) Table China Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table China Urological Cancer Drugs Market Share by Application (2013-2018) Figure Japan Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table Japan Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table Japan Key Players Urological Cancer Drugs Market Share (2017-2018) Table Japan Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table Japan Urological Cancer Drugs Market Share by Type (2013-2018) Table Japan Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table Japan Urological Cancer Drugs Market Share by Application (2013-2018) Figure Southeast Asia Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players Urological Cancer Drugs Market Share (2017-2018) Table Southeast Asia Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table Southeast Asia Urological Cancer Drugs Market Share by Type (2013-2018) Table Southeast Asia Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table Southeast Asia Urological Cancer Drugs Market Share by Application (2013-2018) Figure India Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table India Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table India Key Players Urological Cancer Drugs Market Share (2017-2018) Table India Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table India Urological Cancer Drugs Market Share by Type (2013-2018) Table India Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table India Urological Cancer Drugs Market Share by Application (2013-2018) Figure Central & South America Urological Cancer Drugs Market Size 2013-2018 (Million US$) Table Central & South America Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$) Table Central & South America Key Players Urological Cancer Drugs Market Share (2017-2018) Table Central & South America Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$) Table Central & South America Urological Cancer Drugs Market Share by Type (2013-2018) Table Central & South America Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$) Table Central & South America Urological Cancer Drugs Market Share by Application (2013-2018) Table Novartis Company Details Table Novartis Revenue in Urological Cancer Drugs Business (2013-2018) (Million US$) Figure Novartis Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Pfizer Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Pfizer Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Johnson & Johnson Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure AstraZeneca Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table AstraZeneca Recent Development Table Astellas Company Details Table Astellas Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Astellas Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Astellas Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Bristol-Myers Squibb Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Abbott Laboratories Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Abbott Laboratories Recent Development Table Celgene Corporation Company Details Table Celgene Corporation Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Celgene Corporation Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Celgene Corporation Recent Development Table Dendreon Corporation Company Details Table Dendreon Corporation Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Dendreon Corporation Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Dendreon Corporation Recent Development Table Ferring Pharmaceuticals Company Details Table Ferring Pharmaceuticals Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$) Figure Ferring Pharmaceuticals Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018) Table Ferring Pharmaceuticals Recent Development Table GlaxoSmithKline Company Details Table Indevus Pharmaceuticals Inc Company Details Table Ipsen Company Details Table Roche Healthcare Company Details Table Sanofi S.A Company Details Table Tolmar Inc Company Details Table Global Urological Cancer Drugs Market Size by Regions (Million US$) 2018-2025 Figure Global Urological Cancer Drugs Market Size Share by Regions (2018-2025) Figure Global Urological Cancer Drugs Market Size Share by Regions in 2025 Figure United States Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Figure Europe Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Figure China Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Figure Japan Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Figure India Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Figure Central & South America Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD) Table Global Urological Cancer Drugs Market Size by Product (2018-2025) (Million US$) Figure Global Urological Cancer Drugs Market Size by Product (2018-2025) Figure Global Urological Cancer Drugs Market Size by Product in 2025 Table Global Urological Cancer Drugs Market Size by Application (2018-2025) (Million US$) Figure Global Urological Cancer Drugs Market Size by Application (2018-2025) Figure Global Urological Cancer Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.